Processa Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that…

Biotechnology
US, Hanover [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of PCSA's Analysis
CIK: 1533743 CUSIP: 74275C205 ISIN: US74275C3043 LEI: - UEI: -
Secondary Listings
PCSA has no secondary listings inside our databases.